Source link : https://www.newshealth.biz/health-news/sequencing-in-advanced-urothelial-carcinoma/
The indication for sacituzumab govitecan (Trodelvy) in previously treated patients with locally advanced or metastatic urothelial cancer was withdrawn last month after the drug failed to improve survival versus single-agent chemotherapy in the phase III TROPiCS-04 trial. In light of this changed landscape, Joaquim Bellmunt, MD, PhD, of Dana-Farber Cancer Institute in Boston, discusses second-line […]
Author : News Health
Publish date : 2024-11-01 15:43:57
Copyright for syndicated content belongs to the linked Source.